Literature DB >> 18207587

NT-proBNP on admission for early risk stratification in STEMI patients submitted to PCI. Relation with extension of STEMI and inflammatory markers.

Serafina Valente1, Chiara Lazzeri, Marco Chiostri, Cristina Giglioli, Andrea Sori, Sabrina Tigli, Gian Franco Gensini.   

Abstract

The prognostic implications of NT-proBNP measured on admission in patients with the ST-elevation myocardial infarction (STEMI) are not so far well elucidated. The present investigation, performed in 198 STEMI patients submitted to percutaneous coronary intervention (PCI), was aimed at assessing the prognostic value of NT-proBNP measured on admission to Intensive Cardiac Care Unit (ICCU) and its relation with the extension of myocardial infarction (indicated by cardiac biomarkers and ejection fraction) and inflammatory markers (C-reactive protein - CRP, erythrocyte sedimentation rate - ESR, leucocytes, fibrinogen). All patients who died during ICCU stay had increased values of NT-proBNP. Each quartile of NT-proBNP resulted directly correlated with age, heart rate, peak Tn I, admission creatinine serum levels, ESR, fibrinogen, and inversely correlated with ejection fraction. At backward logistic regression analysis, NT-proBNP values showed a significative correlation with peak Tn I (OR 1.013; 95% CI 1.001-1.025; p=0.036), and CRP positive (OR 6.450; 95% CI 1.714-24.272; p=0.006); age was close to reaching statistical significance (OR 1.043; 95% CI 0.999-1.089; p=0.055). At long term-follow-up NT-proBNP lacks any prognostic role in predicting adverse events such as hospitalization for rePCI, re-infarction and heart failure. Kaplan-Meier curves showed that all patients dead at follow-up were in the highest NT-proBNP quartiles.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18207587     DOI: 10.1016/j.ijcard.2007.10.045

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  13 in total

1.  The prognostic role of gamma-glutamyltransferase activity in non-diabetic ST-elevation myocardial infarction.

Authors:  Chiara Lazzeri; Serafina Valente; Roberto Tarquini; Marco Chiostri; Claudio Picariello; Gian Franco Gensini
Journal:  Intern Emerg Med       Date:  2010-09-29       Impact factor: 3.397

2.  Prevalence, predictors and prognostic significance of microalbuminuria in acute cardiac patients: a single center experience.

Authors:  Serafina Valente; Chiara Lazzeri; Marco Chiostri; Bruno Alterini; Agostino Ognibene; Cristina Giglioli; Clara Pigozzi; Gian Franco Gensini
Journal:  Intern Emerg Med       Date:  2011-05-25       Impact factor: 3.397

3.  Impact of hypertension on short- and long-term prognoses in patients with ST elevation myocardial infarction and without previously known diabetes.

Authors:  Chiara Lazzeri; Serafina Valente; Marco Chiostri; Paola Attanà; Claudio Picariello; Gian Franco Gensini
Journal:  Heart Vessels       Date:  2011-07-07       Impact factor: 2.037

4.  Uric acid in the early risk stratification of ST-elevation myocardial infarction.

Authors:  Chiara Lazzeri; Serafina Valente; Marco Chiostri; Claudio Picariello; Gian Franco Gensini
Journal:  Intern Emerg Med       Date:  2011-01-15       Impact factor: 3.397

5.  Acid-base imbalance in uncomplicated ST-elevation myocardial infarction: the clinical role of tissue acidosis.

Authors:  Chiara Lazzeri; Serafina Valente; Marco Chiostri; Claudio Picariello; Gian Franco Gensini
Journal:  Intern Emerg Med       Date:  2009-12-09       Impact factor: 3.397

6.  Predictors of the early outcome in elderly patients with ST elevation myocardial infarction treated with primary angioplasty: a single center experience.

Authors:  Chiara Lazzeri; Serafina Valente; Marco Chiostri; Claudio Picariello; Gian Franco Gensini
Journal:  Intern Emerg Med       Date:  2010-09-18       Impact factor: 3.397

7.  Acute hyperglycemia and insulin resistance in acute heart failure syndromes without previously known diabetes.

Authors:  Chiara Lazzeri; Serafina Valente; Paola Attanà; Marco Chiostri; Claudio Picariello; Gian Franco Gensini
Journal:  Intern Emerg Med       Date:  2011-05-05       Impact factor: 3.397

8.  Effects of intracoronary injection of autologous bone marrow-derived stem cells on natriuretic peptides and inflammatory markers in patients with acute ST-elevation myocardial infarction.

Authors:  Johanna A Miettinen; Kari Ylitalo; Pirjo Hedberg; Kari Kervinen; Matti Niemelä; Marjaana Säily; Pirjo Koistinen; Eeva-Riitta Savolainen; Heikki Ukkonen; Mikko Pietilä; K E Juhani Airaksinen; Juhani Knuuti; Olli Vuolteenaho; Timo H Mäkikallio; Heikki V Huikuri
Journal:  Clin Res Cardiol       Date:  2010-10-17       Impact factor: 5.460

9.  An Asian validation of the TIMI risk score for ST-segment elevation myocardial infarction.

Authors:  Sharmini Selvarajah; Alan Yean Yip Fong; Gunavathy Selvaraj; Jamaiyah Haniff; Cuno S P M Uiterwaal; Michiel L Bots
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

10.  Kinetic of procalcitonin in patients with cardiogenic shock following acute myocardial infarction: preliminary data.

Authors:  C Picariello; C Lazzeri; M Chiostri; G F Gensini; S Valente
Journal:  HSR Proc Intensive Care Cardiovasc Anesth       Date:  2010
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.